Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Mature B-Cell Lymphoma

St. Jude Children's Research HospitalSmall moleculePhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Mature B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Inno-206
BeOne Medicines
Phase 2/3BB
Cyclophosphamide
BeOne Medicines
Phase 2/3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
BeOne Medicines
Phase 2/3BB
Cytosin-Arabinosid
St. Jude Children's Research Hospital
Phase 2/3B
Copad
St. Jude Children's Research Hospital
Phase 2/3B

View all 11 →

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →